Skip to main content
. 2014 Jan 23;6(1):5043. doi: 10.4081/rt.2014.5043

Table 2.

Outcomes of neuroendocrine bladder cancer based on histology and therapy.

Variable 1-yr
OS, %
3-yr
OS, %
5-yr
OS, %
Median
OS
Log-rank
P-value
Histology
Pure 43
(10-73)
21
(1-58)
21
(1-58)
8 months 0.96
Mixed 54
(23-78)
27
(6-54)
14
(1-42)
25 months  
Therapy
Radical surgery± chemo 64
(30-84)
32
(8-60)
21
(3-49)
26 months 0.42
Other treatment 28
(4-61)
14
(1-46)
14
(1-46)
10 months  

OS, overall survival.